These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 11753639)
1. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation. Nakamura T; Kanda S; Yamamoto K; Kohno T; Maeda K; Matsuyama T; Kanetake H Oncogene; 2001 Nov; 20(52):7610-23. PubMed ID: 11753639 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth. Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613 [TBL] [Abstract][Full Text] [Related]
3. Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis. Day RM; Cioce V; Breckenridge D; Castagnino P; Bottaro DP Oncogene; 1999 Jun; 18(22):3399-406. PubMed ID: 10362361 [TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A. Cacci E; Salani M; Anastasi S; Perroteau I; Poiana G; Biagioni S; Augusti-Tocco G J Neurosci Res; 2003 Dec; 74(5):760-8. PubMed ID: 14635227 [TBL] [Abstract][Full Text] [Related]
6. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991 [TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Matsushita A; Götze T; Korc M Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973 [TBL] [Abstract][Full Text] [Related]
8. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398 [TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival. Qiao H; Hung W; Tremblay E; Wojcik J; Gui J; Ho J; Klassen J; Campling B; Elliott B J Cell Biochem; 2002; 86(4):665-77. PubMed ID: 12210733 [TBL] [Abstract][Full Text] [Related]
10. MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met. Higuchi T; Orita T; Katsuya K; Yamasaki Y; Akiyama K; Li H; Yamamoto T; Saito Y; Nakamura M Mol Cell Biol; 2004 Sep; 24(17):7456-68. PubMed ID: 15314156 [TBL] [Abstract][Full Text] [Related]
11. Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering. Tanimura S; Chatani Y; Hoshino R; Sato M; Watanabe S; Kataoka T; Nakamura T; Kohno M Oncogene; 1998 Jul; 17(1):57-65. PubMed ID: 9671314 [TBL] [Abstract][Full Text] [Related]
12. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer. Maulik G; Kijima T; Ma PC; Ghosh SK; Lin J; Shapiro GI; Schaefer E; Tibaldi E; Johnson BE; Salgia R Clin Cancer Res; 2002 Feb; 8(2):620-7. PubMed ID: 11839685 [TBL] [Abstract][Full Text] [Related]
13. E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells. Hakuma N; Kinoshita I; Shimizu Y; Yamazaki K; Yoshida K; Nishimura M; Dosaka-Akita H Cancer Res; 2005 Dec; 65(23):10776-82. PubMed ID: 16322223 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development. Li G; Schaider H; Satyamoorthy K; Hanakawa Y; Hashimoto K; Herlyn M Oncogene; 2001 Dec; 20(56):8125-35. PubMed ID: 11781826 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases. Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973 [TBL] [Abstract][Full Text] [Related]
16. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. Comoglio PM EXS; 1993; 65():131-65. PubMed ID: 8380735 [TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Recio JA; Merlino G Oncogene; 2002 Feb; 21(7):1000-8. PubMed ID: 11850817 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor activates CCAAT enhancer binding protein and cell replication via PI3-kinase pathway. Cho MK; Kim SG Hepatology; 2003 Mar; 37(3):686-95. PubMed ID: 12601366 [TBL] [Abstract][Full Text] [Related]
19. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1. Jiang Y; Xu W; Lu J; He F; Yang X Biochem Biophys Res Commun; 2001 Sep; 286(5):1123-30. PubMed ID: 11527416 [TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor signal coupling to various transcription factors depends on triggering of Met receptor and protein kinase transducers in human hepatoma cells HepG2. Tacchini L; Dansi P; Matteucci E; Desiderio MA Exp Cell Res; 2000 Apr; 256(1):272-81. PubMed ID: 10739674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]